News

Published on 11 Oct 2024 on GuruFocus.com · via Yahoo Finance

Lexicon Pharmaceuticals Inc (LXRX) Q2 2024 Earnings Call Highlights: Strategic...


Article preview image

Lexicon Pharmaceuticals Inc (LXRX) reports increased R&D and SG&A expenses as it advances its...

NASDAQ.LXRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Lexicon Pharmaceuticals Inc (LXRX) Q3 2024 Earnings Call Highlights: Strategic...

Lexicon Pharmaceuticals Inc (LXRX) showcases progress in clinical developments and strategic...

GuruFocus.com · via Yahoo Finance 13 Nov 2024

Lexicon Pharmaceuticals Inc (LXRX) Q3 2024 Earnings Report Preview: What To Look...

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) is set to release its Q3 2024 earnings on Nov 12, 2024....

GuruFocus.com · via Yahoo Finance 11 Nov 2024

Lexicon Pharmaceuticals Inc (LXRX) Q2 2024 Earnings Call Highlights: Strategic...

Lexicon Pharmaceuticals Inc (LXRX) reports increased R&D and SG&A expenses as it advances its...

GuruFocus.com · via Yahoo Finance 11 Oct 2024

Lexicon Pharmaceuticals, Inc. (LXRX): The Best Multibagger Penny Stock of 2025?

We recently compiled a list of the 10 Best Multibagger Penny Stocks of 2025. In this article, we ...

Insider Monkey · via Yahoo Finance 24 Aug 2024

Private equity firms account for 48% of Lexicon Pharmaceuticals, Inc.'s...

Key Insights Significant control over Lexicon Pharmaceuticals by private equity firms implies tha...

Simply Wall St. · via Yahoo Finance 10 Jul 2024

Lexicon CEO to retire in July after a decade By Investing.com

Lexicon Pharmaceuticals , Inc. (NASDAQ:LXRX) announced today that CEO Lonnel Coats will retire on...

Investing.com 29 Apr 2024

Lexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin

Lexicon Pharmaceuticals, Inc. LXRX announced data from a new post hoc analysis of its phase III i...

Zacks via Yahoo Finance 13 Mar 2024

ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday’s...

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points o...

Benzinga 12 Mar 2024

Lexicon reports positive sotagliflozin trial results

Lexicon Pharmaceuticals , Inc. (NASDAQ: LXRX ) has revealed findings from a post hoc analysis of ...

Investing.com 12 Mar 2024

Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump By Benzinga

Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump

Investing.com 12 Mar 2024